Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil.
Saved in:
| Title: | Risk factors associated with in-hospital mortality during yellow fever outbreak in Brazil. |
|---|---|
| Authors: | McClure M; Division of HIV, Infectious Diseases and Global Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., de Rezende IM; Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States., Pereira LS; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Dutra MRT; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Fradico JRB; Integrated Group of Biomarkers Research, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Macedo R; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Marçal MC; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Fonte Boa LSC; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Bragato AMC; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Faria FAA; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Pamplona L; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Said RFDC; Pan American Health Organization, Brasília, Brazil., Calzavara-Silva CE; Cellular and Molecular Immunology, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Ramalho DB; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Magalhães CLB; Research Center in Biological Sciences, Universidade Federal de Ouro Preto, Ouro Preto, Brazil., Alves PA; Immunology of Viral Diseases, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Gama TDP; Eduardo de Menezes Hospital, Belo Horizonte, Brazil., Cota GF; Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Monath TP; Crozet BioPharma LLC, Lexington, MA, United States., Martins-Filho OA; Integrated Group of Biomarkers Research, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Pascoal-Xavier MA; Immunology of Viral Diseases, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Teixeira-Carvalho A; Integrated Group of Biomarkers Research, Instituto René Rachou, Fundação Oswaldo Cruz (Fiocruz), Belo Horizonte, Brazil., Drumond BP; Laboratory of Viruses, Microbiology Department, Biological Sciences Institute, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil., LaBeaud AD; Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, United States. |
| Corporate Authors: | Yellow Fever Collaborative Group |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2025 Jan 27; Vol. 12, pp. 1505005. Date of Electronic Publication: 2025 Jan 27 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
